Global Systemic Psoriasis Therapeutics Market to grow at a CAGR of 9.41% during 2016-2020

MarketResearchReports.Biz has announced addition of new report “Global Systemic Psoriasis Therapeutics Market 2016-2020” to its database.

About the Systemic Psoriasis Therapeutics Market

Psoriasis is a commonly diagnosed immune-mediated disease of the skin. In psoriasis, the skin grows fast and causes a build-up of red, thick white, or silvery patches. It modifies the normal cell cycle of the skin such that new cells move to the surface of the skin quickly to form patches called plaques. These plaques are commonly found on the knees, elbows, scalp, hand and feet. The condition mostly occurs among adults (18 years-35 years), but can also be seen in adolescents (12 years-18 years) and children (under 10 years).

Psoriasis is more prevalent among Caucasians compared to African-Americans. According to a World Health Organization (WHO) document of 2015, the global prevalence of psoriasis is approximately 2%-3%. However, it is approximately 4.6% in developed countries. In addition, the risk of an individual getting diagnosed with psoriasis is 41% if both parents have psoriasis, 14% in case one parent is affected, and 6% if a sibling has psoriasis.

Technavios analysts forecast the global systemic psoriasis therapeutics market to grow at a CAGR of 9.41% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global systemic psoriasis therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the from the sales of branded, generic, and off-label drugs used to treat psoriasis. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio’s report, Global Systemic Psoriasis Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

 

Key vendors

AbbVie

Johnson & Johnson

Celgene

Amgen

Pfizer

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/756228

 

Other prominent vendors

AbGenomics

Almirall

Anacor Pharmaceuticals

ApoPharma

Astellas Pharma

AstraZeneca

Aurinia Pharmaceuticals

Biocon

Biogen Idec

Biotest

Boehringer Ingelheim

Bristol-Myers Squibb

Can-Fite BioPharma

Cellceutix Corporation

Coherus Biosciences

Creabilis

Crescendo Biologics

Delenex Therapeutics

Dermira

Eli Lilly

  1. Hoffmann-La Roche

Forward Pharma

G & W Laboratories

GlaxoSmithKline

Idera Pharmaceuticals

Incyte

Kadmon

kinetabio

KPI Therapeutics

Kyowa Hakko Kirin

LEO Pharma

Maruho

Merck

Mitsubishi Tanabe Pharma

Moleculin

MorphoSys

Novartis

Prism Pharma

Promius Pharma

Prothena Biosciences

Provectus Biopharmaceuticals

Sandoz

Sun Pharmaceuticals

Takeda Pharmaceuticals

Taro Pharmaceuticals

TFS

UCB

Valeant Pharmaceuticals

VBL Therapeutics

XenoPort

Ziarco Pharma

 

Market driver

Dominance of market by biologics

For a full, detailed list, view our report

 

Market challenge

Physician’s reluctance to prescribe biosimilars

For a full, detailed list, view our report

 

Market trend

Advent of biologics with novel MOA and cell-based strategies

For a full, detailed list, view our report

 

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

%d bloggers like this: